PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.\', \'Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China. liusw@smu.edu.cn.\', \'State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Southern Medical University, Guangzhou, China. liusw@smu.edu.cn.\', \'Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Guangzhou, China. liusw@smu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/978-3-030-63761-3_25
?:doi
?:hasPublicationType
?:journal
  • Advances in experimental medicine and biology
is ?:pmid of
?:pmid
?:pmid
  • 33973193
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.867
?:rankingScore_hIndex
  • 104
?:title
  • Therapeutic Development in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33973193>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33973193>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all